Hydroxychloroquine 200 mg

DRUG2 trials

Sponsors

Medical College of Wisconsin, I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Conditions

Advanced Breast CancerCalcium Pyrophosphate Deposition DiseaseChondrocalcinosisSolid Tumor

Phase 1

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

WithdrawnNCT04316169

Medical College of WisconsinAdvanced Breast Cancer, Solid Tumor

Start: 2021-10-21End: 2028-01-31Updated: 2022-12-23

Phase 2

Baricitinib in CPPD - the BAPTIST Study

Not yet recruitingNCT06768294

I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCalcium Pyrophosphate Deposition Disease, Chondrocalcinosis

Start: 2025-01-31End: 2027-01-31Target: 32Updated: 2025-01-10